In most cases, yes. The Biodiversity Act 2017 regulates access to biological resources and associated traditional knowledge, with particular controls on access by foreign persons and on transferring material or research results abroad. Additional permits may be needed for protected areas, forests, wildlife, fisheries and plant material. Partnering with a Bangladeshi institution helps but does not remove the need for approvals. We review the research plan, identify the approvals required and prepare applications so that fieldwork and sample export are lawful from the start of the project. Early planning avoids delays in the field.

Access and benefit sharing is the principle that people who use genetic resources or traditional knowledge should obtain prior informed consent from the provider country, and from communities where relevant, and agree terms to share the benefits fairly. In practice, it means getting the right approvals before collecting material, signing agreements that define permitted uses and benefit sharing obligations, and keeping records that prove compliance. Benefits can be financial, such as royalties, or non-financial, such as training, joint publications and technology transfer to Bangladeshi institutions. Each element should be documented. We explain each step in plain terms.

Non-commercial research is often treated differently from commercial use, but it is rarely exempt from all requirements, especially where foreign researchers are involved or material leaves Bangladesh. Academic projects usually need approval and an agreement that restricts use to research, sets publication and data terms, and requires new consent if commercial use is later intended. Non-monetary benefit sharing, such as collaboration with Bangladeshi scientists and capacity building, is common. We help academic teams set up proportionate compliance that fits their funding and timetable. Keep records of the material, its source and recipients. Funders increasingly expect this documentation.

This is a common and important scenario. Most approvals and material transfer agreements limit use to the purpose declared when access was granted, so moving from research to commercial development usually requires fresh approval and renegotiated benefit sharing terms. Proceeding without them can expose the user to enforcement in Bangladesh and challenges abroad, including questions over patents or product approvals. We advise on change of intent clauses at the outset and, where results are already valuable, on approaching authorities and partners to regularise the position. Review approval terms once commercial potential appears. Waiting usually makes regularisation harder.

The Biodiversity Act 2017 recognises traditional knowledge associated with biological resources, and access to it is treated alongside access to the resources themselves. Where knowledge comes from identifiable communities, including indigenous peoples in the Chittagong Hill Tracts and elsewhere, consent and benefit sharing should involve those communities directly. Documentation must respect cultural sensitivities and may need confidentiality. We help researchers and companies design respectful processes, record consent properly and negotiate terms that give communities meaningful and lasting benefits from the use of their knowledge. Trust takes time to build. Local partners can help with this.

Possibly, but only with the right approvals and documents. Transfer of biological material or research results out of Bangladesh is a regulated step under the Biodiversity Act 2017, and specimens of CITES-listed species need export permits. Plant, animal and microbial material may also face quarantine and customs requirements in both countries. Couriers have their own rules for biological shipments. We advise on the full export chain and draft material transfer agreements that control onward use by the receiving laboratory and any of its partners. Labels and invoices must match. Delays at customs can damage samples.

They can. Patent offices in some countries require disclosure of the origin of genetic resources or traditional knowledge, and a patent based on unlawfully accessed material may be challenged or create reputational problems. In Bangladesh, patent law has been modernised and its treatment of biological material should be checked for each application. Agreements should also set out who owns resulting inventions. We advise on aligning patent strategy with access approvals and benefit sharing obligations, and on co-ownership and licensing terms with Bangladeshi partners. Early alignment avoids later problems. This should be checked before filing.

Keep copies of approvals and permits, the research proposal submitted, prior informed consent documents, material transfer and benefit sharing agreements, sample collection logs with locations and dates, export permits, shipping records and correspondence with authorities and communities. Track each sample and derivative through your systems so that its provenance can be shown later. Overseas regulators, funders, journals and commercial partners may ask for this evidence. We help clients design simple record systems and review existing collections for gaps. Regular internal audits help keep the record complete and current. Retention periods should be long.